Injector 5280 Inc is categorized under Home Health Care Services in Englewood, CO and active since 2013.
Injector 5280 Inc was established in 2013, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Home Health Care Services business, which does work in the B2C market, and is classified as a Home Health Care Services, under code number 621610 by the NAICS.
If you are seeking more information, feel free to contact April Thompson at the company’s single location by writing to 8400 East Pnp Avenue # 800, Englewood, Colorado CO 80111 or by phoning (303) 803-8786. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Injector 5280 Inc |
| Contact Person: | April Thompson |
| Address: | 8400 East Pnp Avenue # 800, Englewood, Colorado 80111 |
| Phone Number: | (303) 803-8786 |
| Website Address: | injector5280.com |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2013 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Home Health Care Services |
| SIC Code: | 8082 |
| NAICS Code: | 621610 |
| Share This Business: |
Injector 5280 Inc was started in 2013 to provide professional Home Health Care Services under the SIC code 8082 and NAICS code 621610. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact April Thompson for inquiries that concern Injector 5280 Inc by calling the company number (303) 803-8786, as your correspondence is most welcome. Additionally, the physical location of the single location of Injector 5280 Inc can be found at the coordinates 39.570513,-104.979217 as well as the street address 8400 East Pnp Avenue # 800 in Englewood, Colorado 80111.
For its online presence, you may visit Injector 5280 Inc’s website at injector5280.com and engage with its social media outlets through on Twitter and on Facebook.